Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Am J Cardiol. 2016 Apr 6;117(12):1953–1958. doi: 10.1016/j.amjcard.2016.03.046

Table 1.

Participant Characteristics by Cohort

Characteristics ADHF (N=27) Stable HFpEF (N=80) Stable HFrEF (N=56) Healthy (N=61)
Age (years) 72 ± 10 71 ± 7 69 ± 5 69 ± 7
Women 59% 80% 34% 62%
Black 56%* 29% 18% 5%
Body mass index (kg/m2) 29.3±6.7* 31.9±6.5 26.6±4.3 25.9±4.9
Left ventricular ejection fraction (%) 37±16* 62±7 32±10 66±7
Hypertension 89%* 88% 52% N/A
Diabetes mellitus 48%§ 23% 27% N/A
Ischemic heart disease 63% 0% 25% N/A
Diuretic 100% 73% 82% N/A
Beta-blocker 85% 31% 11% N/A
Angiotensin-converting-enzyme inhibitor or Angiotensin II receptor blocker 59% 53% 79% N/A
Digoxin 7% 1% 71% N/A

Data presented as mean ± SD or percentage.

*

ADHF is significantly different from all 3 groups

ADHF is significantly different than HFREF and HFPEF

ADHF is significantly different than HFREF

§

ADHF is significantly different than HFPEF. Comparisons made using analysis of variance for continuous variables and Fisher's exact test for categorical variables.

Abbreviations: ADHF = acute decompensated heart failure; HFpEF = heart failure with preserved ejection fraction; HFrEF = heart failure with reduced ejection fraction; N/A = non-applicable